Scynexis (SCYX) Change in Receivables (2013 - 2023)
Scynexis (SCYX) posted Change in Receivables of -$2.2 million for Q4 2023, down 2167.68% on a QoQ basis from -$99000.0 in Q3 2023, and down 472.7% year-over-year from $602354.6 in Q4 2022.
Scynexis (SCYX) Change in Receivables (2013 - 2023) Analysis & Trends
Scynexis' Change in Receivables history runs 5 years deep, the most recent figure standing at -$2.2 million for Q4 2023.
- Quarterly Change in Receivables fell 472.7% year-over-year to -$2.2 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$2.2 million (down 805.24% YoY) and the FY2023 annual result came in at -$2.1 million, down 269.44% from the prior year.
- Change in Receivables was -$2.2 million for Q4 2023 at Scynexis, down from -$99000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $284000.0 in Q2 2023 and bottomed at -$2.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2.25 Mn |
| Dec 31, 2023 | -2.25 Mn |
| Sep 30, 2023 | -99,000.00 |
| Sep 30, 2023 | -99,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | -41,000.00 |
| Mar 31, 2023 | -41,000.00 |
| Dec 31, 2022 | -392,000.00 |
| Dec 31, 2022 | -392,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Dec 31, 2015 | -554,000.00 |
| Dec 31, 2015 | -554,000.00 |
| Sep 30, 2015 | 309,000.00 |
| Sep 30, 2015 | 309,000.00 |
| Jun 30, 2015 | 662,000.00 |
| Jun 30, 2015 | 662,000.00 |
| Mar 31, 2015 | -448,000.00 |
| Mar 31, 2015 | -448,000.00 |